SGLT Inhibitors in Type 1 Diabetes - New Module Launched
The launch coincides with the recent recommendation by the European Medicines Agency (EMA) for an oral add-on treatment to insulin for certain patients with type 1 diabetes (press release). The module discusses in detail the clinical trials that have been carried out investigating the use of SGLT inhibitors in type 1 diabetes. more